Page last updated: 2024-08-24

2',5'-dideoxyadenosine and B16 Melanoma

2',5'-dideoxyadenosine has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayukawa, K; Murata, J; Ogasawara, M; Saiki, I; Watanabe, H1
Abdel-Malek, ZA; Nordlund, JJ; Swope, VB; Trinkle, LS1

Other Studies

2 other study(ies) available for 2',5'-dideoxyadenosine and B16 Melanoma

ArticleYear
Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by alpha-melanocyte stimulating hormone.
    International journal of cancer, 1999, Mar-15, Volume: 80, Issue:6

    Topics: Adenylyl Cyclase Inhibitors; alpha-MSH; Animals; Biological Factors; Cell Movement; Colforsin; Culture Media, Conditioned; Cyclic AMP; Cycloheximide; Depression, Chemical; Dideoxyadenosine; Melanoma, Experimental; Mice; Neoplasm Proteins; Protein Denaturation; Protein Synthesis Inhibitors; Second Messenger Systems; Tumor Cells, Cultured

1999
Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
    Experimental cell research, 1989, Volume: 180, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Bucladesine; Catechol Oxidase; Cyclic AMP; Dideoxyadenosine; Dideoxynucleosides; Dinoprostone; Interphase; Melanocyte-Stimulating Hormones; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Tumor Cells, Cultured

1989